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Age-Dependent T Cell Tolerance
and Autoimmunity to Myelin Basic Protein
induction (Martin et al., 1992). Myelin basic protein
(MBP), a structural protein in the myelin sheath, is the
major autoantigen targeted in EAE in B10.PL mice. The
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†Department of Molecular Biotechnology majority of CD41 T cells activated by MBP immunization
University of Washington in B10.PL mice recognize a single epitope comprised
Seattle, Washington 98195 of residues MBPAc1-11 associated with I-Au MHC mole-
cules (Zamvil et al., 1986).
Initially, the observation that some MBP-specific T
Summary cells do not undergo immune tolerance was believed
to result from sequestration of MBP within immune-
Experimental autoimmune encephalomyelitis (EAE), privileged sites that allow only limited lymphocyte traf-
an animal model for multiple sclerosis, is induced by ficking. Studies of TCR transgenic mice specific for
activating a subset of myelin basic protein (MBP)-spe- MBPAc1-11 supported this view. Transgenic T cells spe-
cific T cells that have escaped tolerance induction. cific for the MBPAc1-11 epitope do not undergo nega-
Here, we define the tolerance mechanisms that elimi- tive selection in the thymus and populate the periphery
nate the majority of MBP-specific T cells from the in normal numbers (Goverman et al., 1993; Lafaille et
periphery. We show that MBP-specific T cells undergo al., 1994; Liu et al., 1995). Peripheral T cells do not
central tolerance mediated by bone marrow–derived appear to be tolerized, as they remain fully responsive
antigen-presenting cells presenting exogenously de- to stimulation with MBP in vitro. For these reasons,
rived MBP epitopes. The efficiency of tolerance is age MBPAc1-11 TCR transgenic mice have been described
dependent, reflecting the developmentally regulated as a model of T cell ignorance.
expression of MBP. Dependence of tolerance on the Subsequent studies have shown that the immune sys-
amount of MBP expressed in vivo results in an age tem is not ignorant of MBP in vivo. Induction of immune
window of susceptibility to EAE in mice that peaks tolerance to endogenously expressed MBP has been
during puberty. These results suggest that factors reg- directly demonstrated by comparing the T cell response
ulating expression of self-antigens in vivo can influ-
to MBP in wild-type (MBP1/1) and MBP-deficient
ence susceptibility to autoimmunity.
(MBP2/2) shiverer mice. MBP2/2 B10.PL mice generate
a significantly stronger T cell response to MBP than
Introduction
MBP1/1 mice following immunization with MBP. In
MBP2/2 mice, most of the response is directed towardT cell maturation proceeds via a complex sequence of
two epitopes within MBP121-150 rather than towardcell division and differentiation events in the thymus that
MBPAc1-11 (Harrington et al., 1998). These immuno-is tightly regulated by positive and negative selection
genic epitopes induce immune tolerance such thatprocesses (Bevan, 1977; Kappler et al., 1987; Singer et
MBP121-150 represents only a minor part of the weakal., 1999). Positive selection is responsible for skewing
MBP response in wild-type mice. Endogenous MBP hasthe T cell receptor (TCR) repertoire toward recognition
also been shown to induce tolerance in MHC classof foreign antigen associated with self-MHC molecules,
I- and MHC class II–restricted T cells in C3H mice (Tar-while negative selection eliminates T cells expressing
goni and Lehmann, 1998; Huseby et al., 1999).self-reactive TCRs (von Boehmer, 1990). The outcome
The observations that MBP is a targeted antigen inof thymic selection is thought to depend upon the
CNS autoimmune disease and that T cells specific forstrength of interaction between TCRs on developing
the most immunogenic regions of MBP undergo toler-thymocytes and cells expressing peptide/MHC com-
ance suggest that susceptibility to CNS autoimmuneplexes. Thymocytes that have weak but detectable inter-
disease may be regulated by factors influencing the levelactions with their ligands are positively selected, while
of MBP expression in vivo. To test this hypothesis, westronger interactions result in negative selection (Jame-
investigated whether the developmentally regulated ex-son et al., 1995). Peripheral tolerance mechanisms regu-
pression of MBP in vivo influences T cell tolerance andlate T cells specific for self-antigens that escaped cen-
susceptibility to EAE. To carry out these studies, wetral tolerance (Miller et al., 1998; Van Parijs and Abbas,
constructed TCR transgenic mice specific for MBP121-1998).
150 and studied their fate in MBP2/2, MBP1/2, andAlthough central and peripheral tolerance mecha-
MBP1/1 mice at different stages of development. Wenisms eliminate the majority of autoreactive T cells,
show that MBP121-150-specific T cells undergo exten-animal models of T cell–mediated autoimmunity demon-
sive central tolerance induction in MBP1/1 mice, evenstrate that these processes are incomplete. Experimen-
tal autoimmune encephalomyelitis (EAE), an animal though these epitopes are not synthesized in the thy-
model for multiple sclerosis (MS), is induced by activa- mus. We also show that the efficiency of MBP-specific
tion of myelin-specific T cells that escaped tolerance tolerance induction correlates with the amount of MBP
expressed in vivo. Tolerance induction is least effective
during puberty in the transgenic mice, resulting in an‡ To whom correspondence should be addressed (e-mail: goverman@
u.washington.edu). age window of maximum susceptibility to EAE.
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Figure 4 are general characteristics of MBP121-150 T
cells.
MBP121-150 TCR Tg Thymocytes Undergo
Central Tolerance Induction
TCR Tg mice were bred onto the MBP2/2, MBP1/2, and
MBP1/1 B10.PL background to analyze tolerance induc-
tion of MBP-specific T cells. On the MBP2/2 background,
strong positive selection of TCR Tg1 thymocytes was
observed in 4-week-old mice. Mature CD41 single-posi-
tive thymocytes represent 19% of the total thymocyte
population in MBP2/2 mice and express high levels of
the Va2 and Vb8 chains (Figures 1A and 1B). In contrast,
MBP121-150-specific thymocytes undergo extensive
negative selection in the thymus of MBP1/1 mice. Thy-
mocyte cellularity in 4-week-old MBP1/1 TCR Tg mice
is reduced at least 4-fold compared to MBP2/2 TCR Tg
mice, and the CD41 single-positive subset in MBP1/1
mice is severely depleted (Figures 1E and 1F). Expres-
sion of both Va2 and Vb8 is downregulated on CD41
single-positive thymocytes compared to the same sub-
set in MBP2/2 TCR Tg mice. We also analyzed MBP
heterozygous (MBP1/2) TCR Tg mice because MBP ex-
pression in these mice is approximately half that of
MBP1/1 mice (Shine et al., 1992). Interestingly, MBP121-
150-specific thymocytes exhibit an intermediate pheno-
type between MBP2/2 and MBP1/1 TCR Tg mice (Figures
1C and 1D). Although 4-week-old MBP1/2 TCR Tg mice
Figure 1. Efficiency of Negative Selection of MBP121-150-Specific
exhibit significant depletion of the CD41 single-positiveThymocytes in 4-Week-Old TCR Tg Mice Is Dependent upon the
subset, an increased percentage of these cells expressLevel of MBP Expression In Vivo
both Va2 and Vb8, and thymic cellularity is twice thatThymocytes from TCR Tg mice on MBP2/2 (A and B), MBP1/2 (C and
seen in MBP1/1 TCR Tg mice.D), and MBP1/1 (E and F) genetic backgrounds were stained with
antibodies specific for CD4, CD8, Va2, and Vb8. CD41CD82 thymo-
cytes from (A), (C), and (E) were analyzed for the expression of Va2 Tolerance in the Periphery of MBP121-150 TCR
and Vb8 (B, D, and F). Thymic cellularity is shown in parentheses. Tg Mice Reflects MBP Gene Dosage
Data are representative of six to ten littermate TCR Tg mice on each
Significant differences are seen between splenocytesgenetic background.
isolated from 4-week-old TCR Tg MBP1/1, MBP1/2, and
MBP2/2 mice. As expected, the MHC class II restrictionResults
of the Tg TCR results in skewing toward the CD41 subset
in MBP2/2 mice. Greater than 90% of the CD41 T cellsGeneration of MBP121-150-Specific TCR Tg Mice
in MBP2/2 TCR Tg mice coexpress the Va2 and Vb8To follow the fate of T cells specific for MBP121-150,
chains, and greater than 90% of Va21Vb81 splenocytesgenes encoding MBP121-150-specific TCRs were cloned
express CD4 (Figures 2A–2C). In MBP1/2 TCR Tg mice,from MBP121-150-specific T cell clones isolated from
significant tolerance induction is evident by a substantialMBP2/2 mice. Full-length TCR cDNA genes were cloned
decrease in the number of CD41 T cells. Only one thirdfrom two independent T cell clones: one expressing Va2
of the remaining CD41 splenocytes coexpress the Tg apaired with Vb8 and one expressing Va2 paired with
and b chains, and only one quarter of the Va21Vb81Vb4. Availability of antibodies specific for Va2, Vb4, and
splenocytes in these mice express CD4 (Figures 2D–2F).Vb8 enabled us to monitor expression of the intact
In MBP1/1 TCR Tg mice, the number of CD41 T cellstransgenic TCR. TCR genes were subcloned into the
coexpressing the Tg a and b chains is further reduced,T cell–specific transgene (Tg) cassette containing the
and the percentage of Va21Vb81 T cells expressing CD4human CD2 promoter (Zhumabekov et al., 1995). A TCR2
is reduced to less than 10% (Figures 2G–2I).variant D011.10 T cell hybridoma transfected with either
MBP-specific proliferative responses of splenocytesset of TCR Tg constructs expressed the transgenic
from MBP1/1, MBP1/2, and MBP2/2 TCR Tg mice wereTCRs on the cell surface and responded specifically
compared to assess tolerance induction at a functionalto MBP protein and MBP121-150 peptides (data not
level (Figure 2J). Consistent with tolerance mediated byshown). TCR Tg mouse lines were established using
endogenous MBP in a dose-dependent manner, prolifer-both sets of constructs and backcrossed onto the
ation of MBP1/2 TCR Tg splenocytes is somewhat higherB10.PL genetic background. TCR transgenic mice ex-
than the weak response by MBP1/1 TCR Tg splenocytes,pressing Va2 paired with Vb8 were established first and
and both of these responses are significantly less thanhave been used in all experiments described below.
that of MBP2/2 TCR Tg mice. The differences in prolifera-TCR Tg mice expressing Va2 and Vb4 were subsequently
tion reflect in part the relative precursor frequencies ofestablished and confirmed that the phenotypes shown
in Figures 1 and 2 and the response to MBP shown in TCR Tg T cells shown in Figures 2A–2I. To determine if
T Cell Tolerance to MBP
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Figure 2. The Level of MBP Expression In Vivo Affects the Composition and Responsiveness to Antigenic Stimulation of Splenocytes in
4-Week-Old MBP121-150-Specific TCR Tg Mice
Splenocytes from TCR Tg mice on MBP2/2 (A–C), MBP1/2 (D–F), and MBP1/1 (G–I) genetic backgrounds were stained with antibodies specific
for CD4, CD8, Va2, and Vb8. (A), (D), and (G) show CD4 and CD8 expression on splenocytes analyzed through a live gate. (B), (E), and (H)
show Va2 and Vb8 expression on splenocytes analyzed through a CD41 gate. (C), (F), and (I) show CD4 and CD8 expression on splenocytes
analyzed through a Va21Vb81 gate. (J) Proliferative response to MBP121-140 peptide of splenocytes from 4-week-old TCR Tg mice on MBP2/2,
MBP1/2, and MBP1/1 genetic backgrounds. All data are representative of six to ten littermate TCR Tg mice on each genetic background.
the individual T cells remaining in the periphery of 1995). Therefore, it was important to identify which cells
MBP1/1 mice were fully responsive to MBP stimulation, mediated tolerance in the thymus and determine the
splenocytes were stimulated for 18 hr in vitro with MBP source of MBP that these cells present to developing
and stained with antibodies specific for Va2, Vb8, CD25, thymocytes. Radiation bone marrow (BM) chimeras us-
and CD69. Virtually all Va21Vb81 T cells from both ing B10.PL and C3H mice were constructed to determine
MBP1/1 and MBP2/2 mice responded to MBP stimulation whether thymic epithelial cells and/or BM-derived anti-
by downregulating TCR (data not shown). Interestingly, gen-presenting cells (APC) present MBP to the devel-
while 93% of the Tg T cells from MBP2/2 mice expressed oping thymocytes. C3H mice were chosen for genera-
high levels of CD69 and 87% expressed high levels of tion of the chimeras because MBP121-150-specific T
CD25 after stimulation, only 58% of Tg T cells from cells do not respond to C3H splenocytes in vitro and
MBP1/1 mice increased CD69 and 41% increased CD25 because MBP121-150 TCR Tg mice bred onto the C3H
expression. Thus, expression of early activation markers background display a nonselecting phenotype (data not
is impaired in many of the T cells that respond to MBP shown).
stimulation by downregulating TCR in MBP1/1 mice Control chimeric mice in which TCR Tg BM from
compared to MBP2/2 mice. B10.PL mice was transferred into irradiated B10.PL re-
cipients recapitulated the negatively selecting pheno-
type seen on the B10.PL background. The CD41 single-Negative Selection of MBP-Specific Thymocytes
positive subset is diminished, and only half of theseIs Mediated by Bone Marrow–Derived Cells
cells express the Tg TCR (Figure 3A). Chimeric mice inPresenting Exogenous MBP
which the BM-APC are H-2k (nonselecting) and the thy-The observation that MBP121-150-specific T cells un-
mic epithelium is H-2u (selecting) were generated bydergo negative selection in the thymus was surprising
transferring BM from C3H TCR Tg mice into irradiatedbecause transcripts encoding classic MBP isoforms,
MBP1/1 B10.PL recipients. These mice exhibited effi-which contain the MBP121-150 epitopes, have not been
cient positive selection demonstrated by a large CD41detected in the thymus (Campagnoni et al., 1993; Pribyl
et al., 1993; Zelenika et al., 1993; Fritz and Kalvakolanu, single-positive subset in which 90% of the cells express
Immunity
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Figure 3. MBP121-150-Specific Thymocyte Deletion Occurs When BM-APC Process and Present Exogenous MBP to Developing Thymocytes
MBP1/1 B10.PL mice were lethally irradiated and reconstituted with BM isolated from MBP1/1 B10.PL TCR Tg mice (A), MBP1/1 C3H TCR Tg
mice (B), and MBP2/2 B10.PL TCR Tg mice (C). MBP2/2 C3H mice (D and G) and MBP1/1 C3H mice (E and F) were lethally irradiated and
reconstituted with BM isolated from MBP2/2 B10.PL TCR Tg mice (D and F) and MBP1/1 B10.PL TCR Tg mice (E and G). BM chimeras were
analyzed 6 weeks after reconstitution. Data are representative of 6 to 15 mice per type of BM chimera.
Va2 and Vb8 (Figure 3B). Thus, H-2u thymic epithelial single-positive thymocytes and in coexpression of Va21
and Vb81 on the CD41 single-positive thymocytes onlycells promote positive but not negative selection of the
MBP121-150 transgenic T cells. Together, the data in when the C3H recipient mice endogenously expressed
MBP (Figures 3E and 3F). If MBP2/2 recipient mice wereFigures 3A and 3B indicate that negative selection is
mediated by BM-APC. Interestingly, negative selection used, negative selection did not occur even when the
BM was derived from MBP1/1 B10.PL animals (Figureswas still observed in chimeras in which BM derived from
MBP2/2 B10.PL TCR Tg mice was transferred into 3D and 3G). The range in percentage of CD41 single-
positive thymocytes seen in Figures 3D and 3G (6%–MBP1/1 B10.PL recipients (Figure 3C).
The finding that both MBP2/2 and MBP1/1 BM-APC 12%) is consistent with the variability that we observe
in the generation of mature thymocytes in nonselectingcaused equivalent clonal deletion and reduced expres-
sion of the Tg TCR on the few remaining CD41 single- C3H haplotype. These percentages are significantly
higher than those observed in negatively selecting micepositive thymocytes indicated that BM-APC mediate
negative selection by presenting MBP acquired solely (2%–3%) and lower than those seen in positively select-
ing mice (20%–31%). These data show that MBP epi-from the host. This point was further established using
chimeras in which BM from B10.PL TCR Tg mice was topes that mediate negative selection are not endoge-
nously synthesized by BM-APC but are acquired fromtransferred into recipient mice of the nonselecting C3H
haplotype. Although replacing the positively selecting the host and presented in the thymus.
I-Au MHC class II molecules with C3H MHC class II mole-
cules limits the efficiency of positive selection of MBP Is Presented throughout
the Lymphoid SystemMBP121-150-specific T cells (Figure 3D), these BM chi-
meras were able to demonstrate the role of I-Au expres- The finding that exogenous MBP is presented by BM-
APC to thymocytes suggests that BM-APC may presentsion on the BM-APC in negative selection. In these chi-
meras, B10.PL BM-APC induced a reduction in CD41 MBP epitopes to T cells in peripheral lymphoid tissues
T Cell Tolerance to MBP
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tered MBP in lymphoid tissues and not in the CNS, T
cells were isolated from the periphery and CNS of mice
that had received Tg T cells by adoptive transfer. Al-
though proliferating Va21Vb81 T cells were readily de-
tected in the spleen and LN of recipient mice 4 days
after transfer, Tg T cells did not appear in the CNS
until 8 days after transfer (data not shown). These data
indicate that T cells encounter the MBP121-150 epi-
topes in the peripheral lymphoid tissues of mice ex-
pressing endogenous MBP. Interestingly, CFSE-labeled
Tg T cells specific for MBPAc1-11 derived from MBP2/2
mice isolated 4 days after transfer into either MBP1/1
or MBP2/2 recipient mice exhibited a single peak of fluo-
rescence, indicating a failure to respond to their epitope
in lymphoid tissues (Figures 4C and 4D). A large number
of CFSE-negative cells are observed in all profiles, due
to endogenous Va21Vb81 T cells in recipient mice, which
account for z1% of all splenocytes in B10.PL mice (data
not shown). These data indicate that endogenous MBP
expression fails to generate enough MBPAc1-11/I-Au
complexes for T cell activation, yet sufficient numbers
of MBP121-150/MHC complexes are generated in
lymphoid tissues to activate MBP121-150-specific T
cells. A comparison of proliferative responses indicates
MBP121-150-specific T cells are 10–50 times more sen-
sitive to MBP than MBPAc1-11-specific T cells (Figure
4E). Similar results were obtained using both the
Va21Vb41 MBP121-150 TCR Tg mice and T cells from a
separate MBPAc1-11-specific TCR Tg line (Lafaille et
al., 1994) (data not sown). The increased sensitivity ofFigure 4. MBP121-150-Specific T Cells Encounter MBP in the Pe-
MBP121-150-specific T cells to MBP likely reflects theriphery of Wild-Type Mice and Are Activated by Lower Concentra-
tions of MBP than MBPAc1-11-Specific T Cells very long half-life of MBP121-150/MHC complexes com-
CFSE-labeled spleen and LN cells derived from MBP121-150-spe- pared to MBPAc1-11/MHC complexes (Mason et al.,
cific MBP2/2 TCR Tg mice (A and B) or from MBPAc1-11-specific 1995; Harrington et al., 1998).
MBP2/2 TCR Tg mice (C and D) were transferred intravenously into
either MBP2/2 (A and C) or MBP1/1 (B and D) recipient mice. Four
Tolerance to MBP Is Developmentally Regulateddays later, splenocytes from recipient mice were stained with Va2
The results described above indicate that endogenousand Vb8, and Va21Vb81-gated cells were analyzed for CFSE expres-
sion. Similar profiles were seen for Va21Vb81 T cells harvested from MBP is presented by APC in lymphoid tissues and that
inguinal and cervical LN of recipient mice (data not shown). CFSE the extent of T cell tolerance induced by these APC is
transfer profiles and proliferation responses are representative of a function of the amount of MBP expressed in vivo.
five individual experiments. Splenocytes from MBP121-150 or Because expression of MBP in vivo increases during
MBPAc1-11 MBP2/2 TCR Tg mice were stimulated in vitro with vari-
development, these observations raised the question ofous concentrations of whole MBP protein (E).
whether tolerance induction would also be developmen-
tally regulated. MBP is first detected in the mouse brain
between birth and 5 days of age, and its expressionas well. To investigate this question, naive T cells iso-
lated from MBP2/2 TCR Tg mice were fluorescently la- increases until it reaches a steady-state level at 6 weeks
of age (Barbarese et al., 1978; Mathisen et al., 1993). Tobeled with 5,6-carboxyfluorescine diacetate succinimi-
dyl ester (CFSE) ex vivo and injected into either MBP1/1 determine whether T cell tolerance is affected by the
developmental expression of MBP, thymocyte andor MBP2/2 recipient mice. Four days posttransfer, T cells
from the thymus, spleen, inguinal, and cervical lymph splenocyte populations in MBP2/2, MBP1/2, and MBP1/1
TCR Tg mice were analyzed at different ages. In MBP2/2nodes (LN) were harvested and analyzed for expression
of CFSE. Cervical LN were analyzed separately because TCR Tg mice, efficient positive selection in the thymus
is observed at all time points examined between 2 andthey have been implicated as the draining LN of the CNS
(Cserr and Knopf, 1992; Pereira et al., 1994). MBP121- 10 weeks of age. In 2- and 3-week-old MBP1/1 TCR Tg
mice, thymic cellularity was similar to that seen in150-specific T cells isolated from the spleen (Figure 4A)
and LN (data not shown) of MBP2/2 recipient mice exhib- MBP2/2 mice; however, the number of CD41Va21Vb81
single-positive thymocytes was lower (p , 0.01) (Figuresited a single peak of fluorescence, indicating that the
transgenic T cells had not proliferated. In contrast, 5A and 5B). In 4-week-old mice, both thymic cellularity
(p , 0.001) and number of CD41Va21Vb81 single-posi-MBP121-150-specific T cells isolated from the lymphoid
organs of MBP1/1 recipient mice had proliferated exten- tive thymocytes (p , 0.001) are greatly decreased in
MBP1/1 compared to MBP2/2 TCR Tg mice. The differ-sively (Figure 4B). Tg T cells isolated from inguinal LN,
cervical LN, and spleen proliferated equivalently. No ences in thymic cellularity and number of CD41Va21Vb81
single-positive thymocytes in MBP1/1 versus MBP2/2CFSE-labeled cells were recovered from the thymus
(data not shown). To confirm that the Tg T cells encoun- mice increase as the mice age, with the greatest differ-
Immunity
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Figure 5. Efficiency of Tolerance Induction of MBP121-150 TCR Tg T Cells Is Determined by MBP Gene Dosage and Age
Thymic cellularity of TCR Tg mice on MBP2/2, MBP1/2, and MBP1/1 genetic backgrounds was determined at various ages (A). Thymocytes
from TCR Tg mice at various ages were stained with CD4-, CD8-, Va2-, and Vb8-specific antibodies to determine the total number of
CD41CD82Va21Vb81 thymocytes (B). Splenic cellularity was determined in TCR Tg mice on MBP2/2, MBP1/2, and MBP1/1 genetic backgrounds
at various ages (C). Splenocytes from TCR Tg mice were stained with CD4-, CD8-, Va2-, and Vb8-specific antibodies to determine the total
number of Va21Vb81 (D) and CD41Va21Vb81 (E) splenocytes. Proliferative responses to 1 mM MBP of splenocytes from each age and genetic
background are shown in (F). For 2-week-old mice, n 5 4 for MBP2/2 Tg, n 5 7 for MBP1/2 Tg, and n 5 6 for MBP1/1 Tg; for 3-week-old mice,
n 5 5 for MBP2/2 Tg, n 5 7 for MBP1/2 Tg, and n 5 9 for MBP1/1 Tg; for 4-week-old mice, n 5 10 for MBP2/2 Tg, n 5 9 for MBP1/2 Tg, and
n 5 15 for MBP1/1 Tg; for 6-week-old mice, n 5 6 for Tg MBP2/2, n 5 8 for MBP1/2 Tg, and n 5 9 for MBP1/1 Tg; for 10-week-old mice, n 5
4 for MBP2/2 Tg, n 5 7 for MBP1/2 Tg, and n 5 8 for MBP1/1 Tg. Error bars indicate one standard deviation.
ences observed between 10-week-old MBP1/1 and negative selection efficiency is dependent upon both
age and MBP gene dosage in MBP121-150-specific TCRMBP2/2 animals. A similar developmental increase in
negative selection was observed in MBP1/2 TCR Tg Tg mice.
Developmental effects on the peripheral T cell com-mice; however, there are some interesting differences.
At 4 weeks of age, MBP1/2 TCR Tg mice displayed an partment were also observed in MBP2/2, MBP1/2, and
MBP1/1 TCR Tg mice. The total number of splenocytesintermediate phenotype in which the cellularity and
number of CD41Va21Vb81 single-positive thymocytes and number of Va21Vb81 splenocytes in Tg mice on all
backgrounds increased as mice aged from 2 to 4 weekswas significantly lower than in MBP2/2 TCR Tg mice (p ,
0.01 for cellularity and thymocyte number) but higher and then remained fairly constant (Figures 5C and 5D).
MBP2/2 TCR Tg mice consistently had a higher numberthan in MBP1/1 TCR Tg mice (p , 0.01 for cellularity
and thymocyte number). Both MBP1/1 and MBP1/2 TCR of CD41Va21Vb81 splenocytes compared to MBP1/2 and
MBP1/1 mice at all ages (p , 0.001 for all ages). TheTg mice exhibited a reduction in thymic cellularity and
number of CD41Va21Vb81 single-positive thymocytes in most striking difference between MBP2/2, MBP1/2, and
MBP1/1 mice was observed when comparing numbers10-week-old mice compared to 2- and 3-week-old mice
(p , 0.01 for cellularity and thymocyte number). Thus, of CD41Va21Vb81 T cells (Figure 5E). The number of
T Cell Tolerance to MBP
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CD41Va21Vb81 T cells increased in all mice but to dif- more pronounced. Expression of Vb8 on MBP1/1 com-
fering degrees between 2 and 4 weeks of age. After 4 pared to MBP2/2 thymocytes was 52% 6 2.8%, 44% 6
weeks of age, the number of CD41Va21Vb81 T cells did 4.3%, and 30% 6 3.4% at 2, 4, and 10 weeks of age,
not appreciably change in any mice. Again, 4-week-old respectively. The downregulation that occurred in the
MBP1/2 TCR Tg mice exhibited an intermediate pheno- thymus is reflected in peripheral T cells. Relative Va2
type such that the number of CD41Va21Vb81 spleno- expression on MBP1/1 compared to MBP2/2 splenocytes
cytes was less than the number in 4-week-old MBP2/2 was 81% 6 3.7%, 72% 6 3.1%, and 54% 6 3.7% at
TCR Tg mice (p , 0.001) but significantly greater than 2, 4, and 10 weeks of age, respectively. Relative Vb8
the number in MBP1/1 TCR Tg mice (p , 0.001). By 10 expression on MBP1/1 splenocytes was 66% 6 3.3%,
weeks of age, both MBP1/2 and MBP1/1 TCR Tg mice 65% 6 3.8%, and 45% 6 5.8% at 2, 4, and 10 weeks
exhibited a comparable reduction in CD41Va21Vb81 of age, respectively. Thus, the lower level of TCR expres-
splenocytes relative to MBP2/2 TCR Tg mice. sion on MBP1/1 Tg T cells in 10-week-old compared to
To assess the effect of developmentally regulated 4-week-old mice is consistent with the reduced prolifer-
MBP expression on functional tolerance in TCR Tg mice, ative response to MBP.
proliferative responses from MBP2/2, MBP1/2, and
MBP1/1 TCR Tg mice were compared. Strong prolifera- Developmentally Regulated Tolerance
tive responses to MBP were generated from MBP2/2 Induction Results in an Age Window
TCR Tg splenocytes at all ages between 2 and 10 weeks of Susceptibility to Autoimmunity
(Figure 5F). Proliferative responses from MBP1/2 and The observation that splenocyte proliferative responses
MBP1/1 TCR Tg mice increased between 2 and 4 weeks, to MBP peak at 4 weeks of age and then decline in
reflecting the increase in number of CD41Va21Vb81 T MBP1/2 and MBP1/1 TCR Tg mice suggested that sus-
cells in the periphery of these mice. The proliferative ceptibility to autoimmune disease may also peak at this
responses from MBP1/1 and MBP1/2 TCR Tg mice both age. We determined whether susceptibility to EAE would
peak at 4 weeks of age. Although maximum proliferative be dependent on age and/or the MBP gene copy number
responses are observed at this age, 4-week-old MBP1/1 by injecting 4- and 10-week-old MBP1/2 and MBP1/1
TCR Tg mice still generated a significantly decreased TCR Tg mice with pertussis toxin. Previous studies have
response to MBP compared to MBP1/2 TCR Tg mice shown that a high incidence of EAE is induced in
(p , 0.05), reflecting the gene dosage effect on accumu- MBPAc1-11 TCR Tg mice by injection of pertussis toxin
lation of CD41Va21Vb81 T cells seen in Figure 5E. Inter- alone (Goverman et al., 1993). This protocol allowed us
estingly, proliferative responses in both MBP1/2 and to assess the autoimmune potential of the peripheral T
MBP1/1 TCR Tg mice decreased between 4 and 10 cells without altering the T cell compartment by immuni-
weeks of age, even though CD41Va21Vb81 T cell num- zation with antigen. In 4-week-old mice, the incidence
bers do not decline (p , 0.05 for MBP1/1 mice; p , 0.01 of disease was 100% in MBP1/2 TCR Tg mice but
for MBP1/2 mice). dropped to 52% in MBP1/1 TCR Tg mice (p , 0.01)
The decline in proliferative responses but not number (Table 1). In addition to gene dosage effects, susceptibil-
of CD41Va21Vb81 T cells in MBP1/2 and MBP1/1 TCR ity to EAE exhibited a significant dependence on age.
Tg mice between 4 and 10 weeks of age suggested The incidence in MBP1/2 TCR Tg mice dropped from
that Tg T cells remaining in the periphery of older mice 100% in 4-week-old mice to 39% in 10-week-old mice
become less responsive to MBP. Analyses of the ex- (p , 0.001) and from 52% to 16% in MBP1/1 TCR Tg
pression levels of Tg TCR chains on peripheral T cells mice (p , 0.05). Interestingly, there was no significant
provided an explanation for this decrease in response
difference between 10-week-old MBP1/1 and MBP1/2
to antigenic stimulation. The levels of Va2 and Vb8 ex- TCR Tg mice (p 5 0.23), consistent with comparable
pression progressively decrease on CD41 single-posi-
numbers of CD41Va21Vb81 T cells and proliferative re-tive thymocytes and splenocytes in MBP1/1 mice com-
sponses to MBP in these mice at 10 weeks (Figure 5F).pared to MBP2/2 mice as the animals age from 2 to 10
weeks (Figure 6). Gates for Va21 and Vb81 expression
Discussionshown in Figure 6 were defined by the Va21 and Vb81
populations in nontransgenic mice. The data shown in
We were motivated to investigate how the immune sys-Figures 6G, 6H, 6K, and 6L demonstrate that, although
tem establishes and maintains tolerance to MBP, be-similar numbers of T cells in 4- and 10-week-old mice
cause MBP is a targeted antigen in CNS autoimmunelie within the positive gates for Va2 and Vb8 expression,
disease. We were particularly interested in determiningTg T cells in the spleens of 10-week-old MBP1/1 mice
how tolerance is induced to an antigen expressed onlyexpress substantially lower levels of Va2 and Vb8 com-
in myelin-forming cells and whether developmental reg-pared to Tg T cells in 4-week-old MBP1/1 mice. To quan-
ulation of MBP expression affects tolerance inductiontify this phenomenon, the relative expression of Tg TCR
and ultimately susceptibility to autoimmune disease.chains on MBP1/1 compared to MBP2/2 Tg T cells was
The MBP121-150 TCR Tg mice bred onto the MBP2/2,calculated as a percentage obtained by dividing the
MBP1/2, and MBP1/1 genetic backgrounds allowed usmean fluorescence of Va2 or Vb8 staining in MBP1/1 T
to investigate these issues.cells by the mean fluorescence observed in MBP2/2 T
Our results indicate that substantial T cell tolerancecells and multiplying by 100. The relative expression of
to MBP121-150 occurs through negative selection in theVa2 on thymocytes in MBP1/1 compared to MBP2/2 mice
thymus. This observation was surprising to us becausewas 63% 6 4.1% at 2 weeks (n 5 6), 53% 6 4.7% at 4
transcripts containing the MBP121-150 epitopes haveweeks (n 5 7), and 34% 6 3.6% at 10 weeks (n 5 5).
Interestingly, downregulation of the Vb81 chain was even only been isolated from myelin-forming cells (Trapp et
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Figure 6. Age-Dependent Downregulation of
the MBP121-150 Tg TCR
T cells from MBP1/1 (bold line) and MBP2/2
(thin line) Tg mice at 2 (A–D), 4 (E–H), and 10
(I–L) weeks of age were analyzed. Expression
of Va2 was determined on CD41 single-posi-
tive Vb81 thymocytes (A, E, and I) and Vb81
splenocytes (C, G, and K). Expression of Vb8
was determined on CD41 single-positive
Va21 thymocytes (B, F, and J) and Va21 splen-
ocytes (D, H, and L). Data are representative
of at least four mice at each age and genetic
background.
al., 1987; Verity and Campagnoni, 1988). MBP expres- tive selection occurs when BM-APC acquire MBP exog-
enously and present the MBP epitopes to developingsion outside the nervous system has been intensely
investigated following the observation that the MBP thymocytes. All lymphoid tissues, including the thymus,
are innervated, and MBP produced by Schwann cells isgene is part of a 105 kb gene complex referred to as
the golli-MBP gene complex (Campagnoni et al., 1993; present in the myelin sheath surrounding axons in these
tissues. Degradation of myelin within lymphoid tissuesPribyl et al., 1993; Zelenika et al., 1993). This complex
encodes two families of transcripts referred to as golli- may be the source of MBP presented by BM-derived
cells. The process of negative selection of MBP-specificMBP and classic MBP transcripts. Golli-MBP transcripts
contain three unique exons spliced to several of the thymocytes is distinct from recent studies describing
central tolerance to proteolipid protein (PLP)-specificexons encoding classic MBP sequences and are found
in thymus, spleen, and LN as well as the CNS and periph- thymocytes because tolerogenic PLP epitopes appear
to be synthesized by thymic epithelial cells and BM-eral nervous system (Mathisen et al., 1993; Pribyl et al.,
1993; Zelenika et al., 1993). Thus, there is a clear poten- APC (Anderson et al., 2000; Klein et al., 2000).
Studies using fetal thymic organ cultures and TCR Tgtial for expression of golli-MBP proteins in the thymus
and periphery to play a role in tolerance induction to mice injected with cognate antigens suggest that the
efficiency of negative selection is dependent upon themany MBP epitopes. The MBP121-150 epitopes, how-
ever, are not found in golli-MBP (Mathisen et al., 1993; concentration of the selecting antigen within the thymus
(Murphy et al., 1990; Spain and Berg, 1992; VasquezZelenika et al., 1993; Fritz and Kalvakolanu, 1995; Landry
et al., 1996), indicating that T cell tolerance in MBP121- et al., 1992; Liu et al., 1995). We addressed whether
physiological changes in MBP expression levels in vivo150-specific TCR Tg mice occurs through interactions
with classic MBP. were sufficient to affect the efficiency of tolerance induc-
tion of MBP121-150-specific T cells. MBP is first de-Previous studies showed that both thymic epithelial
cells and BM-APC can mediate negative selection by tected within the brain between birth and day 5, and its
expression increases until it reaches steady-state levelspresenting peptides processed from endogenous and
exogenously derived proteins (Anderson et al., 1996; 6 weeks after birth (Barbarese et al., 1978; Mathisen et
al., 1993). The MBP gene is normally transcribed fromStockinger, 1999). Analysis of MBP121-150 TCR Tg BM
chimeras, in which either thymic epithelial cells or BM- both alleles, such that MBP1/2 mice generate half the
total MBP protein as wild-type mice (Shine et al., 1992).APC were of the H-2u selecting haplotype, indicated that
thymic epithelial cells mediate positive but not negative Our results indicate that efficiency of tolerance induc-
tion in the thymus and periphery of MBP121-150 TCRselection of MBP121-150-specific thymocytes. Nega-
Table 1. Susceptibility to EAE Is Dependent upon Age and MBP Gene Dosage
Average Day Average Maximum
Mice Age Incidence of Onset Clinical Score
Tg MBP1/2 4 weeks 15/15 13 6 5 3.2 6 1.6
Tg MBP1/1 4 weeks 13/25 15 6 4 2.0 6 1.0
Tg MBP1/2 10 weeks 5/13 14 6 2 2.6 6 1.4
Tg MBP1/1 10 weeks 2/12 11 6 1 1.5 6 0.7
Mice were injected with pertussis toxin and monitored for 60 days. Significant differences in susceptibility to EAE were observed in 4-week-
old compared to 10-week-old MBP1/2 mice (p , 0.001), 4-week-old compared to 10-week-old MBP1/1 mice (p , 0.05), and MBP1/2 versus
MBP1/1 TCR Tg mice at 4 weeks (p , 0.01).
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Tg mice is dependent upon both age and MBP gene mice, however, suggesting that additional peripheral tol-
dosage. This effect is particularly obvious when com- erance mechanisms inhibit MBP121-150-specific T cell
paring both thymic cellularity and the number of responses in vivo.
CD41Va21Vb81 single-positive thymocytes in MBP2/2, The finding that proliferative responses of splenocytes
MBP1/2, and MBP1/1 mice. Thymic cellularity is similar from MBP1/2 and MBP1/1 TCR Tg mice to MBP121-150
in 2- to 3-week-old MBP1/1 and MBP2/2 TCR Tg mice peak at 4 weeks of age and then decrease as mice
(Figure 5). The number of CD41Va21Vb81 single-positive age suggests that changes in efficiency of tolerance
thymocytes is reduced in MBP1/1 mice compared to induction to MBP during development result in an age-
MBP2/2 mice, however, suggesting that some MBP may dependent window of increased susceptibility to CNS
be presented in the thymus as early as 2–3 weeks of autoimmune disease. The data further predicted that
age. At 4 weeks of age and later, thymic cellularity is susceptibility to CNS autoimmunity would increase
sharply reduced in both MBP1/1 and MBP1/2 TCR Tg within this age window in MBP1/2 versus MBP1/1 mice
mice compared to MBP2/2 TCR Tg mice. Four-week-old due to MBP gene dosage. These predictions were con-
MBP1/2 TCR Tg mice exhibit an intermediate phenotype firmed by comparing susceptibility to EAE induction in
between MBP2/2 and MBP1/1 TCR Tg mice, supporting MBP1/2 versus MBP1/1 TCR Tg mice at different ages.
the idea that the efficiency of MBP-specific negative Correlating with the developmental changes in tolerance
selection is dependent upon the amount of MBP pre- efficiency, 4-week-old MBP1/2 TCR Tg mice had the
sented within the thymus. By 10 weeks of age, both highest incidence of disease, while 10-week-old MBP1/1
MBP1/2 and MBP1/1 TCR Tg mice exhibit extensive neg- TCR Tg mice had the lowest incidence.
ative selection compared to both 10-week-old MBP2/2 Studies of human disease have suggested that varia-
TCR Tg mice and to 2-week-old MBP1/1 and MBP1/2 tion in expression of autoantigens in the thymus may
TCR Tg mice. Thus, the increase in efficiency of thymic
influence susceptibility to autoimmune disease. A corre-
deletion correlates with accumulation of MBP in vivo.
lation has been shown between allelic variants of a dia-
Our results also indicate that tolerance induction of
betes susceptibility locus and transcription levels of pro-MBP121-150-specific T cells occurs in the periphery as
insulin and insulin in the thymus early in life (Pugliesewell as the thymus. Peripheral tolerance appears to play
et al., 1997; Vafiadis et al., 1997). In MS, genetic suscep-a role in modulating CD4 expression on Tg splenocytes
tibility has so far been consistently associated only within young MBP1/1 mice. A comparison between 2-week-
MHC class II alleles (McFarland et al., 1997). Studiesold MBP1/1 and MBP2/2 mice reveals a much greater
presented here suggest that genetic variation in factorsreduction in CD41Va21Vb81 splenocytes than in the total
modulating expression of MBP or other myelin antigensnumber of Va21Vb81 splenocytes in MBP1/1 mice (Fig-
could also influence MS susceptibility. Although the eti-ures 5D and 5E). These data suggest that Tg T cells
ology of MS is unknown, a prominent paradigm sup-downregulate CD4 in the periphery of MBP1/1 mice.
ported by epidemiological studies (Kurtzke, 1997) sug-Because the downregulation of CD4 in Tg splenocytes
gests that exposure of susceptible individuals to ain MBP1/1 mice is more apparent in 2- and 3-week-old
pathogen prior to the age of puberty initiates the patho-mice than older mice, we speculate that this phenome-
genesis of MS. It is interesting to speculate that thenon may be related to the fact that synthesis of MBP is
early age at which people appear to be susceptible toincreasing rapidly during the first few weeks of life. Thus,
this first environmental trigger may correspond to a pe-Tg T cells found in the periphery of 2-week-old mice
were educated in younger thymuses, where they were riod of reduced efficiency of tolerance induction to my-
exposed to less MBP. When they emigrate to the periph- elin antigens in prepubescent juveniles relative to adults.
ery, the level of MBP has increased, and the Tg T cells If susceptibility to MS is regulated at least in part by the
may downregulate CD4 to maintain peripheral tolerance. efficiency of tolerance induction to myelin antigens, then
The amount of MBP expressed in vivo at 4 weeks of it is important to study not only the T cells that escape
age results in more negative selection in the thymus and tolerance in adults but also T cells that undergo substan-
less need for downregulation of CD4 in the periphery. tial yet incomplete tolerance.
Peripheral tolerance involving modulation of the Tg
TCR occurs as Tg MBP1/1 mice age from 4 to 10 weeks.
Experimental ProceduresAs shown in Figure 5, the number of CD41Va21Vb81 T
cells does not decrease, but their proliferative response
Miceto MBP declines. The age-dependent downregulation
B10.PL (73 NS)/Sn, C3HeB/FeJ, and C3HeB/FeJ-MBPshi/1 were pur-of Tg TCR chains shown in Figure 6 provides an explana-
chased from Jackson Laboratory (Bar Harbor, ME) and bred in a
tion for the decrease in responsiveness to MBP in older specific pathogen–free facility at the University of Washington.
mice. If the number of MBP121-150-specific TCRs on B10.PL MBP2/2 mice were generated by backcrossing the shi muta-
the cell surface drops below a critical threshold, the T tion (Dupouey et al., 1979; Kirschner and Ganser, 1980; Roach et
al., 1985) ten generations onto the B10.PL background. The MBPshi/1cells may not receive sufficient signals to initiate activa-
genotype was identified by PCR (Mathisen et al., 1993), and MBPshi/shition (Viola and Lanzavecchia, 1996). Despite these
(MBP2/2) mice were identified by whole-body tremor. MBPAc1-11mechanisms, a small number of MBP121-150-specific
TCR Tg mice have been previously described (Goverman et al.,Va21Vb81 T cells remain in older MBP1/1 mice that can
1993; Lafaille et al., 1994).respond to MBP. These T cells should encounter MBP
in the spleen and LN, as illustrated by the proliferation
of naive CFSE-labeled MBP121-150 TCR Tg T cells Synthetic Peptides
transferred into MBP1/1 mice. We have observed no HPLC-purified MBP121-140 peptide was purchased from Research
Genetics (Huntsville, AL).cases of spontaneous EAE in the MBP121-150 TCR Tg
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Generation of Transgenic Mice Expressing was supported by National Institutes of Health (NIH) Grant
R01NS35126 to J. G. NIH Grant P30AG13280 supported generationMBP121-150-Specific TCRs
Full-length rearranged TCR cDNAs for the TCRa and -b chains were of transgenic mice. E. S. H. was supported by an NIH Predoctoral
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Vb4, TCCTGTGTGACACTGCTATGG; and Cb1, GGATCCCTTCAT Received November 9, 2000; revised February 15, 2001.
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